相约星期六

黑猴引爆中国3A!大厂砸钱《影之刃零》就是完美例子_我的网站

血色浪漫

一 | 据外媒报道，《黑神话：悟空》的现象级成功彻底撬动了中国游戏行业的投资风向，资本正大规模从服务型游戏赛道，转向拥有完整叙事结构的第三人称单机 3A 作品。行业分析指出，《黑神话：悟空》向市场验证了高成本单机作品可同时实现口碑与商业双丰收，打破了此前投资方对单机 3A 赛道的风险顾虑，大量资金随之涌入该领域。

二 | CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。

三 | 其中灵游坊旗下《影之刃零》是典型案例，本作在《黑神话：悟空》出圈后获得巨额追加融资，投资邀约蜂拥而至，工作室甚至不得不婉拒部分合作方。

四 | 官方也表示，此前国内市场与技术尚不足以支撑主机级游戏开发，新一轮投资正重塑整个行业格局。腾讯旗下 Eclipse Glow Games 开发的《湮灭之潮》同样引人注目，该作跳出中国神话题材，以亚瑟王传说为蓝本、伦敦为故事背景，瞄准全球市场，开发团队汇集了曾参与《刺客信条》《女神异闻录》等系列的资深开发者。目前国内已有《失落之魂》《明末：渊虚之羽》等多个单机 3A 项目稳步推进，厂商普遍转向有完整叙事的单机体验，避开同质化的战斗通行证与持续付费模式。业内认为这并非短期热潮，《黑神话：悟空》的成功大幅降低了单机赛道的投资风险预期，若趋势延续，未来国产 3A 将具备与欧美日厂商同台竞技的实力。